We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


University of Glasgow Genomics Facility Selects GenoLogics for Systems Biology Solution

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "University of Glasgow Genomics Facility Selects GenoLogics for Systems Biology Solution"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:

GenoLogics Life Sciences Software Inc. (GenoLogics), a developer of lab and data management software solutions, has announced that the University of Glasgow’s Sir Henry Wellcome Functional Genomics Facility (SHWFGF), recently installed GenoLogics’ Proteus solution for their proteomics research and will be adding the Geneus solution to tackle their genomics research projects in the near future. 

GenoLogics will provide the Sir Henry Wellcome Functional Genomics Facility and the RASOR Interdisciplinary Research Collaboration with a solution for systems biology that enables a cross-science approach to genomics and proteomics research.

Dr. Andrew Pitt, Director of the Sir Henry Wellcome Functional Genomics Facility and RASOR, stated, “We chose GenoLogics because of its partnering philosophy and commitment to systems biology and open standards, as well as its ability to customize a cross-science solution combining genomics and proteomics, with the promise of further developments in new fields.  This will greatly enhance the productivity of the SHWFGF and our RASOR initiative.”

Dr. Pitt continued, “I’m increasingly convinced that it is crucial that software and database informatics technologies complement and accelerate the use of proteomics and genomics instrumentation and technologies in order to make research advances."

"The GenoLogics solution integrates with our instruments and allows flexible workflows, which frees our researchers to focus on science rather than data management issues.”

GenoLogics looks forward to developing a long-term partnership with the SHWFGF and supporting its goal of becoming a European leader in multidisciplinary functional genomics research. 

Michael Ball, GenoLogics CEO said, “We are very impressed with the range of technologies being developed in the Glasgow facility.  We are particularly looking forward to their feedback once our new Geneus solution is installed and operating alongside Proteus, which will enable the Facility to combine proteomics and gene expression data in real systems biology applications.”

The University of Glasgow’s Sir Henry Wellcome Functional Genomics Facility combines in genomics, proteomics, tissue microanalysis, and bioinformatics with the aim of promoting biological and biomedical research by providing efficient service to the research community in Scotland and beyond.